Industry-representing associations are often perplexed among various opinions of businesses of all sizes. Unlike small and medium-sized companies urging the regulation to be versatile for the survival of many companies, large corporations focus more on industry support and advancement. Often, the companies express contrasting opinions on a same regulation.

The industry association, supposed to generally cover all member companies, gets into an internal dispute when it loses balance among them. And pharmaceutical industry associations were no exception. When the industry was sensitive with the drug pricing system revision in early 2019, many of small and medium-sized companies talked of collectively le